Voyager Therapeutics Inc (VYGR)
R&D Expense Growth
-10.41%
Quarterly · Period ending:
VYGR R&D Expense Growth
Latest reported-10.41%period ending
Latest reported-10.41%period ending
VYGR Quarterly R&D Growth (QoQ) (0.00% → -10.41%)
Latest values, visible window
High-resolution chart · PNG
VYGR r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -10.4097% | |
| -31.5699% | |
| 0.2398% | |
| 14.4781% | |
| -0.6217% | |
| -11.4015% | |
| 17.6648% | |
| -12.2228% | |
| 33.0399% | |
| 6.0399% | |
| -5.5755% | |
| 17.6393% | |
| 18.4026% | |
| 27.6064% | |
| -24.7505% | |
| 54.3626% | |
| -12.6977% | |
| 2.3466% | |
| -21.7372% | |
| -8.1569% | |
| -12.7137% | |
| 1.5912% | |
| -12.153% | |
| -14.8999% | |
| -8.8902% | |
| -11.6467% | |
| 22.7491% | |
| 4.2028% | |
| 15.082% | |
| 46.8074% | |
| 1.6955% | |
| 0.7573% | |
| 11.1358% | |
| 11.4504% | |
| -31.8695% | |
| 27.8497% | |
| 8.7265% | |
| 10.6028% | |
| 23.4164% | |
| -1.6692% | |
| 20.0641% | |
| -5.2928% | |
| 42.262% | |
| 0.4028% | |
| 16.8749% | |
| 86.5878% | |
| 23.3847% | |
| 13.8586% | |
| 47.1369% | |
| 0% |